Linz Valerie Catherine, Battista Marco Johannes, Hummel Regina, Schepers Markus, Griemert Eva-Verena, Schmidt Mona Wanda, Schmidt Marcus, Hasenburg Annette, Gillen Katharina
Department of Obstetrics and Gynecology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Department of Gynecology, Diakonie Hospital Jung-Stilling Siegen, Siegen, Germany.
Oncol Res Treat. 2025;48(6):341-350. doi: 10.1159/000543540. Epub 2025 Feb 25.
Epidural anesthesia is a standard procedure to mitigate pain during surgery for endometrial cancer (EC). Little data exist about the influence of epidural anesthesia on the oncological outcome in elderly patients with EC. This retrospective study aimed to investigate potential correlations between epidural anesthesia and cancer recurrence in patients with EC.
We screened the medical records of patients ≥60 years treated surgically for EC at the University Medical Center Mainz between January 2008 and December 2019. All women underwent general anesthesia (GA) alone or combined with epidural anesthesia (EGA). Cox regression, the Kaplan-Meier method and propensity score matching were used to analyze the prognostic influence of the anesthesiologic regime on survival.
A total of 152 women with EC were included. Twenty-nine patients (19.1%) formed the EGA cohort. The median time of follow-up (FU) was 31 months (interquartile range [IQR]: 8-67.5). The EGA cohort showed more in-hospital complications (27.6 vs. 8.9%; p = 0.006), especially thromboembolic events (3 vs. 0 events; p = 0.006), as well as a longer hospital stay (11 [IQR: 8-13] vs. 7 [IQR: 4-9] days; p < 0.001). Twenty-six patients (17.1%) developed a recurrence in the follow-up at a median of 13 months [IQR: 7.75-29.5]. Thirty-two patients died during FU (21.1%). The EGA cohort showed higher FIGO stages and a higher histological grading than the GA cohort. In the Kaplan-Meier analysis, EGA showed a significantly reduced 5-year recurrence-free survival (RFS) (36.5% vs. 72.6%, p < 0.001) and overall survival (OS) (58.6% vs. 79.9%, p = 0.008). However, in multivariate Cox regression analysis including FIGO stages and histological grading, EGA did not influence RFS (HR: 2.02; 95%-CI: [0.99-4.12], p = 0.054), and OS (HR: 1.03; 95%-CI: [0.40-2.66], p = 0.951). This was backed up by the propensity score- matched analysis for survival (RFS: p = 0.604, OS: p = 0.86).
Considering risk factors, epidural anesthesia in combination with GA did not differ in recurrence-free and overall survival compared to GA. Prospective randomized trials are warranted in order to further evaluate this topic.
硬膜外麻醉是减轻子宫内膜癌(EC)手术期间疼痛的标准操作。关于硬膜外麻醉对老年EC患者肿瘤学结局的影响,相关数据较少。这项回顾性研究旨在调查硬膜外麻醉与EC患者癌症复发之间的潜在相关性。
我们筛选了2008年1月至2019年12月在美因茨大学医学中心接受手术治疗的≥60岁EC患者的病历。所有女性均单独接受全身麻醉(GA)或联合硬膜外麻醉(EGA)。采用Cox回归、Kaplan-Meier法和倾向得分匹配法分析麻醉方式对生存的预后影响。
共纳入152例EC女性患者。29例患者(19.1%)组成EGA队列。中位随访时间(FU)为31个月(四分位间距[IQR]:8 - 67.5)。EGA队列的院内并发症更多(27.6%对8.9%;p = 0.006),尤其是血栓栓塞事件(3例对0例;p = 0.006),且住院时间更长(11天[IQR:8 - 13]对7天[IQR:4 - 9];p < 0.001)。26例患者(17.1%)在随访期间出现复发,中位复发时间为13个月[IQR:7.75 - 29.5]。32例患者在随访期间死亡(21.1%)。EGA队列的国际妇产科联盟(FIGO)分期和组织学分级高于GA队列。在Kaplan-Meier分析中,EGA显示5年无复发生存率(RFS)显著降低(36.5%对72.6%,p < 0.001)和总生存率(OS)显著降低(58.6%对79.9%,p = 0.008)。然而,在包括FIGO分期和组织学分级的多变量Cox回归分析中,EGA对RFS(风险比[HR]:2.02;95%置信区间[CI]:[0.99 - 4.12],p = 0.054)和OS(HR:1.03;95%CI:[0.40 - 2.66],p = 0.951)无影响。这一结果得到了生存倾向得分匹配分析的支持(RFS:p = 0.604,OS:p = 0.86)。
考虑到风险因素,与GA相比,GA联合硬膜外麻醉在无复发生存率和总生存率方面并无差异。有必要进行前瞻性随机试验以进一步评估该主题。